Urologix Reports Fiscal Year 2013 First Quarter Results and Revises Annual Guidance

Published: Nov 15, 2012

MINNEAPOLIS, Nov. 14, 2012 (GLOBE NEWSWIRE) -- Urologix®, Inc. (Nasdaq:ULGX), the leading provider of in-office procedures for the safe, durable and effective treatment of BPH, today reported financial results for its fiscal year first quarter ended September 30, 2012.

Back to news